Mortality in Hepatitis C Populations: Another Battle Against Drugs and Alcohol.
In the era of efficacious and well-tolerated treatment for chronic hepatitis C virus (HCV) infection, there is an expanding population of individuals who achieve viral eradication. This in turn has generated a need to determine the impact of liver-related morbidity and mortality, particularly liver decompensation and hepatocellular carcinoma, in populations achieving sustained viral response (SVR), and how they correlate with that of the general population.
Department of Infectious Diseases, University Hospital Crosshouse, Kilmarnock, Scotland.
James E
JE
Burns
D019698:Hepatitis C, Chronic / Q000188:drug therapy / Q000401:mortality* / Q000821:virology; D006801:Humans; D012309:Risk-Taking